UroGen Pharma Ltd. (URGN)
USD 10.79
(-4.77%)
USD 10.79
(-4.77%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -76.37 Million | -87.55 Million | -84.89 Million | -105.88 Million | -71.01 Million | -37.33 Million |
| Net Income | -102.24 Million | -109.78 Million | -110.82 Million | -128.48 Million | -105.14 Million | -75.65 Million |
| Depreciation & Amortization | 1.7 Million | 1.81 Million | 1.77 Million | 2.04 Million | 1.32 Million | 417 Thousand |
| Deferred income taxes | -68 Thousand | - | 15.32 Million | 439 Thousand | -572 Thousand | - |
| Stock-based compensation | 9.34 Million | 10.58 Million | 23.11 Million | 28.02 Million | 29.96 Million | 30.64 Million |
| Change in working capital | 3.33 Million | -6.3 Million | -13.1 Million | -6.36 Million | 4.32 Million | 7.16 Million |
| Other non-cash items | 11.55 Million | 16.13 Million | -1.17 Million | -1.54 Million | -910 Thousand | 100 Thousand |
| Investing Cash Flow | -953 Thousand | 1.06 Million | 4.06 Million | 93.23 Million | -145.59 Million | 35.28 Million |
| Investments in PPE | -194 Thousand | -254 Thousand | -752 Thousand | -1.21 Million | -325 Thousand | -560 Thousand |
| Acquisitions | 759 Thousand | -1.31 Million | -4.82 Million | -94.45 Million | - | - |
| Investment purchases | -49.83 Million | -63 Million | -51.89 Million | -29.68 Million | -197.68 Million | -54 Thousand |
| Sales/Maturities of investments | 49.07 Million | 64.32 Million | 56.71 Million | 124.14 Million | 52.59 Million | 35.9 Million |
| Other Investing Activities | -759 Thousand | 1.31 Million | 4.82 Million | 94.45 Million | -172 Thousand | -54 Thousand |
| Financing Cash Flow | 116.93 Million | 97.13 Million | 72.31 Million | 16.52 Million | 165.25 Million | 66.42 Million |
| Debt repayment | - | -95.78 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 116.93 Million | 1.35 Million | -83 Thousand | 15.85 Million | 165.25 Million | 64.23 Million |
| Other Financing Activities | 116.93 Million | 1.35 Million | 72.4 Million | 674 Thousand | 165.25 Million | 2.18 Million |
| Accounts receivables | -2.73 Million | -987 Thousand | -4.67 Million | -7.04 Million | - | 3.29 Million |
| Accounts payables | 4.15 Million | 281 Thousand | 1.99 Million | -1.24 Million | 2.92 Million | 4.2 Million |
| Inventory | -1.34 Million | -362 Thousand | -2.86 Million | -1.96 Million | - | 316 Thousand |
| Other working capital | 3.26 Million | -5.23 Million | -7.56 Million | 3.88 Million | 1.39 Million | -650 Thousand |
| Cash at beginning of period | 56.22 Million | 45.58 Million | 54.09 Million | 50.21 Million | 101.57 Million | 37.19 Million |
| Cash at end of period | 95.82 Million | 56.22 Million | 45.58 Million | 54.09 Million | 50.21 Million | 101.57 Million |
| Capital Expenditure | -194 Thousand | -254 Thousand | -752 Thousand | -1.21 Million | -325 Thousand | -560 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 39.6 Million | 10.63 Million | -8.5 Million | 3.87 Million | -51.36 Million | 64.37 Million |
| Free Cash Flow | -76.57 Million | -87.81 Million | -85.64 Million | -107.1 Million | -71.34 Million | -37.89 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -23.67 Million | -33.4 Million | -32.28 Million | -102.24 Million | -26.01 Million | -21.87 Million |
| Depreciation & Amortization | 266 Thousand | 263 Thousand | 351 Thousand | 1.7 Million | 424 Thousand | 415 Thousand |
| Deferred income taxes | - | - | - | -68 Thousand | -4.24 Million | 2.77 Million |
| Stock-based compensation | 3.48 Million | 3.56 Million | 2.75 Million | 9.34 Million | 2.61 Million | 2.22 Million |
| Change in working capital | 1.44 Million | 2.56 Million | -4.01 Million | 3.33 Million | 6.58 Million | -1.05 Million |
| Other non-cash items | -9.19 Million | 3.26 Million | 1.45 Million | 11.55 Million | 7.58 Million | 222 Thousand |
| Investing Cash Flow | -106.75 Million | 11.99 Million | 13.51 Million | -953 Thousand | -10.98 Million | 401 Thousand |
| Investments in PPE | -96 Thousand | -84 Thousand | - | -194 Thousand | -53.54 Thousand | -100 Thousand |
| Acquisitions | - | - | - | 759 Thousand | 11.28 Million | -501 Thousand |
| Investment purchases | -118.79 Million | - | - | -49.83 Million | -14.17 Million | -10.83 Million |
| Sales/Maturities of investments | 12.14 Million | 12.08 Million | 13.51 Million | 49.07 Million | 3.24 Million | 11.33 Million |
| Other Investing Activities | - | 12.08 Million | 13.51 Million | -759 Thousand | -11.28 Million | 501 Thousand |
| Financing Cash Flow | 39.6 Million | 100.28 Million | 54.65 Million | 116.93 Million | 40 Thousand | 116.07 Million |
| Debt repayment | - | - | - | - | -741.85 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -136.16 Million | 81.5 Million | 54.65 Million | 116.93 Million | -377.96 Thousand | 112.4 Million |
| Other Financing Activities | 175.77 Million | 18.77 Million | 54.65 Million | 116.93 Million | 40 Thousand | 116.07 Million |
| Accounts receivables | -5.38 Million | -3.25 Million | 1.28 Million | -2.73 Million | -2.5 Million | 2.65 Million |
| Accounts payables | -4.06 Million | 5.59 Million | 1.62 Million | 4.15 Million | 2.36 Million | -2.32 Million |
| Inventory | -152 Thousand | -199 Thousand | -1.57 Million | -1.34 Million | -645.04 Thousand | -14 Thousand |
| Other working capital | 4.91 Million | 427 Thousand | -5.34 Million | 3.26 Million | 7.36 Million | -1.37 Million |
| Cash at beginning of period | 220.79 Million | 132.26 Million | 95.82 Million | 56.22 Million | 120.12 Million | 20.94 Million |
| Cash at end of period | 125.98 Million | 220.79 Million | 132.26 Million | 95.82 Million | 95.82 Million | 120.12 Million |
| Capital Expenditure | -96 Thousand | -84 Thousand | - | -194 Thousand | -53.54 Thousand | -100 Thousand |
| Effect of forex changes on cash | - | - | - | - | -623.94 Thousand | - |
| Net cash flow / Change in cash | -94.8 Million | 88.53 Million | 36.44 Million | 39.6 Million | -24.29 Million | 99.17 Million |
| Free Cash Flow | -27.76 Million | -23.83 Million | -31.73 Million | -76.57 Million | -13.1 Million | -17.39 Million |
OCEAW
CYIENT
ROOPAIND
BCCLF
OWLI
BBOX